Growth capital specialists in the technology, life sciences and renewable energy sectors.
We are passionate about investing in growth-focused companies.
Keep up to date with what is going on at Deepbridge, our investee companies and other exciting news.
An opportunity to participate in a range of diverse portfolios, proactively managed by our sector experienced team. Tax advantages are potentially available via the Enterprise Investment Scheme and Seed Enterprise Investment Scheme. Please view our specific product pages for more information. Financial Advice is recommended.
No management charges are levied on the investor at the point of investment for advised subscriptions received by a financial adviser, resulting in up to 100% allocation of subscription. This ensures up to 100% tax efficiency for investors. Deepbridge Capital fees are paid by Investee Companies and are disclosed in the Information Memorandum.
Deepbridge Capital aims to redefine the growth capital market by providing investors with access to opportunities which are sourced, reviewed and managed by our team of sector specialists.
Supporting energetic, passionate and knowledgeable management teams, Deepbridge seeks to identify highly innovative companies to grow into highly successful companies, with a view to providing optimal returns to our investors.
As investment specialists in the technology, life sciences and renewable energy sectors, we work with investee companies throughout their funding journey with an eye always on producing a suitable exit for our investors.
Managing Partner
Technical Partner
Partner & Head of Life Sciences
Partner & Chief Financial Officer
It is important for us to work in partnership with supporters who share our passion for what we do, and therefore Deepbridge has been a fantastic partner for Sky Medical Technology. Their understanding of the commercialisation process of a tech company such as ours has been a real asset. Bernard Ross, Sky Medical Technology Limited (CEO)
"It was extremely important for Elasmogen that we worked with the right funding partners. Deepbridge’s life Sciences team understands our company and our sector, with their support therefore being invaluable and much appreciated .”
Caroline Barelle, Elasmogen Limited (CEO)
Having consistently demonstrated their faith in our proposition and our objectives, we have been delighted to work with the Deepbridge team as Arbnco has grown. Their commercial experience and their genuine commitment to working in partnership with us has been invaluable. Maureen Eisbrenner, arbnco (CEO)
Want to know more? Get in touch
